Evidence map›Paper›PMID 41169499›Full record

ArticleiScience2025

Measles trend in Gabon: Insight from 18 years of surveillance data.

Guy Francis Nzengui Nzengui, Hervé M'boyis Kamdem, Ayawa Claudine Kombila Koumavor, Gaël Mourembou, Pélagie Mougola Bissiengou, Daniella Delpo, Rotimi Myrabelle Avome Houechenou, Fabrice Lotola Mougeni, Fortune Barondi Diambou, Annie Badila Missogni and 15 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Guy Francis Nzengui NzenguiDépartement de Bactériologie-Virologie, Institut Supérieur de Biologie Médicale, Université des Sciences de la Santé Libreville, Libreville, Gabon.
Hervé M'boyis KamdemDépartement de Bactériologie-Virologie, Institut Supérieur de Biologie Médicale, Université des Sciences de la Santé Libreville, Libreville, Gabon.
Ayawa Claudine Kombila KoumavorDépartement de Bactériologie-Virologie, Institut Supérieur de Biologie Médicale, Université des Sciences de la Santé Libreville, Libreville, Gabon.
Gaël MourembouDépartement de Bactériologie-Virologie, Institut Supérieur de Biologie Médicale, Université des Sciences de la Santé Libreville, Libreville, Gabon.
Pélagie Mougola BissiengouDépartement de Bactériologie-Virologie, Institut Supérieur de Biologie Médicale, Université des Sciences de la Santé Libreville, Libreville, Gabon.
Daniella DelpoLaboratoire National de Santé Publique, Libreville, Gabon.
Rotimi Myrabelle Avome HouechenouLaboratoire National de Santé Publique, Libreville, Gabon.
Fabrice Lotola MougeniCenter for Medical Data Science, Medical University of Vienna, Vienna, Austria.
Fortune Barondi DiambouProgramme Elargi de Vaccination, Ministère de la Santé Libreville, Libreville, Gabon.
Annie Badila MissogniProgramme Elargi de Vaccination, Ministère de la Santé Libreville, Libreville, Gabon.
Frédéric NgoulouProgramme Elargi de Vaccination, Ministère de la Santé Libreville, Libreville, Gabon.
Marcel Mouketou MabikaProgramme Elargi de Vaccination, Ministère de la Santé Libreville, Libreville, Gabon.
Thierry MbaProgramme Elargi de Vaccination, Ministère de la Santé Libreville, Libreville, Gabon.
Alain Mombo MomboCenter for Medical Data Science, Medical University of Vienna, Vienna, Austria.
Paulin MbagouProgramme Elargi de Vaccination, Ministère de la Santé Libreville, Libreville, Gabon.
Urlucha Marina Mbani OkoumbaService d'Immunologie Clinique, Département des Sciences fondamentales, Faculté de médecine, Université des Sciences de la Santé Libreville, Libreville, Gabon.
Alyssa SbarraDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Saki TakahashiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Anicet Christel Maloupazoa SiawayaLaboratoire National de Santé Publique, Libreville, Gabon.
Amandine Mveang NzogheLaboratoire National de Santé Publique, Libreville, Gabon.
Ofilia Mvoundza NdjindjiLaboratoire National de Santé Publique, Libreville, Gabon.
Samira Zoa AssoumouDépartement de Bactériologie-Virologie, Institut Supérieur de Biologie Médicale, Université des Sciences de la Santé Libreville, Libreville, Gabon.
Ann MoormaanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Joel Fleury Djoba SiawayaLaboratoire National de Santé Publique, Libreville, Gabon.
Angélique Ndjoyi MbiguinoDépartement de Bactériologie-Virologie, Institut Supérieur de Biologie Médicale, Université des Sciences de la Santé Libreville, Libreville, Gabon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Measles is a vaccine-preventable infection that can lead to serious illness and death. The delayed implementation of the World Health Organization (WHO)-recommended two doses of measles-containing vaccine (MCV1 and MCV2) and immunity gaps compromise the effort to elimination. Eighteen years (2006-2023) of surveillance data from Gabon measles surveillance program were collected and analyzed. Variables included age, sex, vaccination status and date, disease date, and anti-measles immunoglobulin M (IgM) status (determined by immunoassay). The rate of infection and association studies was done. Results showed that 60.6% (1,640/2,708) of suspected cases were unvaccinated against measles. Of suspected cases, 26.1% were laboratory-confirmed cases. Unvaccinated individuals were 5.9-7.7 times more likely to be anti-measles IgM positive (

Indexed as

Medical surveillancePublic healthVirology

Identifiers

PMID41169499
PMCPMC12570359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.